Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-26-054057
Filing Date
2026-08-06
Accepted
2026-08-06 12:15:24
Documents
78
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ocgn-20260630.htm   iXBRL 10-Q 1099757
2 EX-31.1 ocgn-2026630x10qxex311.htm EX-31.1 9961
3 EX-31.2 ocgn-2026630x10qxex312.htm EX-31.2 9680
4 EX-32.1 ocgn-20260630x10qxex321.htm EX-32.1 7250
10 ocgn-20260630_g1.jpg GRAPHIC 27940
  Complete submission text file 0001628280-26-054057.txt   7421708

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ocgn-20260630.xsd EX-101.SCH 50195
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ocgn-20260630_cal.xml EX-101.CAL 69975
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ocgn-20260630_def.xml EX-101.DEF 270027
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ocgn-20260630_lab.xml EX-101.LAB 679755
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ocgn-20260630_pre.xml EX-101.PRE 491739
82 EXTRACTED XBRL INSTANCE DOCUMENT ocgn-20260630_htm.xml XML 916601
Mailing Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355
Business Address 11 GREAT VALLEY PARKWAY MALVERN PA 19355 484-328-4701
Ocugen, Inc. (Filer) CIK: 0001372299 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36751 | Film No.: 261247753
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)